A multiomics disease progression signature of low-risk ccrcc

HIGHLIGHTS

• who: Philipp Strauss from the DepartmentUniversity of have published the article: A multiomics disease progression signature of low-risk ccRCC, in the Journal: Scientific Reports Scientific Reports
• what: The Regional Ethics Committee (REC) of Western Norway approved this study (REC no. 78-05), and all methods were carried out in accordance with relevant guidelines and regulations, including the declaration of Helsinki.
• how: The authors obtained sequencing data related to the identified genes from the GDC TCGA Kidney Clear Cell Carcinoma (KIRC) study utilizing the Xena Functional Genomics Explorer (https//u200bxenabu200browser.u200bnet/)34.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.